Pelvic lymph node displacement in high-risk prostate cancer patients treated with image guided intensity modulated radiation therapy with 2 independent target volumes

被引:5
作者
Lecavalier-Barsoum, Magali [1 ]
Souhami, Luis [1 ]
Cury, Fabio [1 ]
Duclos, Marie [1 ]
Ruo, Russel [2 ]
Faria, Sergio [1 ]
机构
[1] McGill Univ Hlth Ctr, Montreal Gen Hosp, Dept Radiat Oncol, Montreal, PQ, Canada
[2] McGill Univ Hlth Ctr, Montreal Gen Hosp, Dept Med Phys, Montreal, PQ, Canada
关键词
D O I
10.1016/j.prro.2015.05.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate the displacement of the pelvic lymph node (PLN) target when using cone beam computed tomography (CBCT) for localization of the prostate in patients treated with simultaneous integrated boost. Methods and materials: High-risk prostate cancer patients treated with image guided intensity modulated radiation therapy with simultaneous integrated boost receiving 60 Gy in 20 fractions to the prostate and proximal seminal vesicles (PTV60) and 44 Gy in the same 20 fractions to the PLN (PTV44) were studied. Two hundred weekly CBCTs of 50 patients were retrospectively reviewed to assess the displacement of the iliac vessels compared with the simulation computed tomography. For each CBCT, possible displacements were analyzed at 3 levels of PTV44: a superior, middle, and inferior slice, making a total of 600 slices reviewed. Geographical miss (GM) was defined when any part of the iliac vessels on the CBCT was outside of the PTV44 contour. Results: GMwas found in 7 of the 600 CBCT slices, all in different patients. All GMs were of <= 5 mm. Four GMs occurred on the middle slice and 3 on the superior slice. In 3 cases, the GM was related to shifts >= 7 mm applied to the prostate. Conclusions: Our review suggests that for high-risk prostate cancer, the chance of not appropriately covering the PLN target after adjusting the prostate is low. GMwas uncommon and in the order of only a few millimeters when it occurred. (C) 2015 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:406 / 410
页数:5
相关论文
共 13 条
  • [1] Repeat CT-scan assessment of lymph node motion in locally advanced cervical cancer patients
    Bondar, Luiza
    Velema, Laura
    Mens, Jan Willem
    Zwijnenburg, Ellen
    Heijmen, Ben
    Hoogeman, Mischa
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (12) : 1104 - 1110
  • [2] Alignment Focus of Daily Image Guidance for Concurrent Treatment of Prostate and Pelvic Lymph Nodes
    Ferjani, Samah
    Huang, Guangshun
    Shang, Qingyang
    Stephans, Kevin L.
    Zhong, Yahua
    Qi, Peng
    Tendulkar, Rahul D.
    Xia, Ping
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : 383 - 389
  • [3] A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes
    Hsu, Annie
    Pawlicki, Todd
    Luxton, Gary
    Hara, Wendy
    King, Christopher R.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (03): : 898 - 902
  • [4] Whole-Pelvic Nodal Radiation Therapy in the Context of Hypofractionation for High-Risk Prostate Cancer Patients: A Step Forward
    Kaidar-Person, Orit
    Roach, Mack
    Crehange, Gilles
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (04): : 600 - 605
  • [5] Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer
    Li, XA
    Wang, JZ
    Jursinic, PA
    Lawton, CA
    Wang, D
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (04): : 1251 - 1257
  • [6] An algorithm for shifting MLC shapes to adjust for daily prostate movement during concurrent treatment with pelvic lymph nodes
    Ludlum, Erica
    Mu, Guangwei
    Weinberg, Vivian
    Roach, Mack, III
    Verhey, Lynn J.
    Xia, Ping
    [J]. MEDICAL PHYSICS, 2007, 34 (12) : 4750 - 4756
  • [7] TOXICITY ASSESSMENT OF PELVIC INTENSITY-MODULATED RADIOTHERAPY WITH HYPOFRACTIONATED SIMULTANEOUS INTEGRATED BOOST TO PROSTATE FOR INTERMEDIATE- AND HIGH-RISK PROSTATE CANCER
    McCammon, Robert
    Rusthoven, Kyle E.
    Kavanagh, Brian
    Newell, Sherri
    Newman, Francis
    Raben, David
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (02): : 413 - 420
  • [8] Validation of an online replanning technique for prostate adaptive radiotherapy
    Peng, Cheng
    Chen, Guangpei
    Ahunbay, Ergun
    Wang, Dian
    Lawton, Colleen
    Li, X. Allen
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 2011, 56 (12) : 3659 - 3668
  • [9] ACUTE TOXICITY IN HIGH-RISK PROSTATE CANCER PATIENTS TREATED WITH ANDROGEN SUPPRESSION AND HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY
    Pervez, Nadeem
    Small, Cormac
    MacKenzie, Marc
    Yee, Don
    Parliament, Matthew
    Ghosh, Sunita
    Mihai, Alina
    Amanie, John
    Murtha, Albert
    Field, Colin
    Murray, David
    Fallone, Gino
    Pearcey, Robert
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (01): : 57 - 64
  • [10] Cone beam CT pre- and post-daily treatment for assessing geometrical and dosimetric intrafraction variability during radiotherapy of prostate cancer
    Reggiori, Giacomo
    Mancosu, Pietro
    Tozzi, Angelo
    Cantone, Marie C.
    Castiglioni, Simona
    Lattuada, Paola
    Lobefalo, Francesca
    Cozzi, Luca
    Fogliata, Antonella
    Navarria, Piera
    Scorsetti, Marta
    [J]. JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2011, 12 (01): : 141 - 152